{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-072340","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2025-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.852696+00:00","generated_at":"2026-05-23T22:44:54.259328+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Chief Medical Officer Eyal Attar resigns effective April 18, 2025","bullets":["Eyal C. Attar, M.D., resigned as Chief Medical Officer of Vor Biopharma, effective April 18, 2025.","Resignation is to pursue a new opportunity; no successor named yet.","Company expects to enter into a consulting agreement for transition services.","Dr. Attar's departure may impact ongoing clinical development activities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-072340","json":"https://secwatch.observer/filing/0001193125-25-072340.json","markdown":"https://secwatch.observer/filing/0001193125-25-072340.md","text":"https://secwatch.observer/filing/0001193125-25-072340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525072340/0001193125-25-072340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525072340/d932261d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T22:44:54.259328+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9e159c845","claim":"Eyal C. Attar, M.D. resigned as Chief Medical Officer at Vor Biopharma Inc..","evidence_excerpt":"On March 31, 2025, Eyal C. Attar, M.D., notified Vor Biopharma Inc. (the “Company”) of his decision to resign as Chief Medical Officer of the Company, effective as of April 18, 2025, in order to pursue a new opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525072340/0001193125-25-072340-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}